- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 14 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.13: 2 residues within 4Å:- Chain C: N.45, N.259
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.15: 5 residues within 4Å:- Chain C: H.129, V.132, K.151, K.173, N.175
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.19: 6 residues within 4Å:- Chain A: D.869, D.871, N.872, Q.992
- Chain C: V.1201, N.1202
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:D.869, A:N.872, A:D.869
- 31 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.20: 2 residues within 4Å:- Chain A: N.6, N.9
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain A: N.179, S.181, T.182
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain A: V.651, N.653
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain A: H.671, N.673, Y.734
Ligand excluded by PLIPNAG.24: 1 residues within 4Å:- Chain A: N.767
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain A: N.784, I.1142
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain A: A.912, N.915
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain B: N.6
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain B: N.45, N.259
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain B: H.129, V.132, E.134, N.175
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain B: N.179, S.181, T.182
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain B: S.234, N.235, T.236, N.238
Ligand excluded by PLIPNAG.33: 4 residues within 4Å:- Chain B: N.342, S.344, T.345, D.595
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain B: F.323, I.419, N.420
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain B: N.457, S.521
- Chain C: K.79
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain B: N.551
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain B: N.673, Y.734, N.735
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain B: D.606, V.607, N.691, N.692
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain B: N.784
Ligand excluded by PLIPNAG.40: 4 residues within 4Å:- Chain B: E.911, A.912, N.915, S.920
Ligand excluded by PLIPNAG.42: 5 residues within 4Å:- Chain C: N.16, T.18, V.19, R.21, L.75
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain C: F.10, N.158
Ligand excluded by PLIPNAG.44: 4 residues within 4Å:- Chain C: S.234, T.236, D.237, N.238
Ligand excluded by PLIPNAG.45: 6 residues within 4Å:- Chain B: A.514, Y.515
- Chain C: D.313, N.340, N.342, L.597
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain C: F.323, I.419, N.420
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain C: V.651, N.653
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain C: D.606, V.607, N.691, N.692
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain C: S.720, N.762
Ligand excluded by PLIPNAG.50: 1 residues within 4Å:- Chain C: N.767
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Chain C: N.784
Ligand excluded by PLIPNAG.52: 3 residues within 4Å:- Chain C: E.911, A.912, N.915
Ligand excluded by PLIP- 3 x 01: 5-acetamido-8-O-(5-acetamido-9-O-acetyl-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl)-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosonic acid
01.27: 18 residues within 4Å:- Chain A: N.13, L.15, T.17, T.18, L.66, K.67, G.68, T.69, Y.71, L.72, S.73, W.76, C.229, N.230, A.231, S.233, N.235, T.236
16 PLIP interactions:16 interactions with chain A- Hydrophobic interactions: A:T.18, A:L.66, A:Y.71, A:T.236
- Hydrogen bonds: A:N.13, A:T.17, A:T.17, A:K.67, A:K.67, A:K.67, A:T.69, A:T.69, A:T.69, A:S.233, A:N.235
- Salt bridges: A:K.67
01.41: 15 residues within 4Å:- Chain B: N.13, L.15, T.17, K.67, G.68, T.69, T.70, Y.71, L.72, S.73, W.76, I.232, S.233, N.235, T.236
16 PLIP interactions:16 interactions with chain B- Hydrophobic interactions: B:L.15, B:T.17, B:W.76, B:N.235
- Hydrogen bonds: B:T.17, B:K.67, B:T.69, B:T.69, B:T.69, B:T.70, B:T.70, B:Y.71, B:S.73, B:S.233, B:N.235
- Salt bridges: B:K.67
01.53: 13 residues within 4Å:- Chain C: N.13, T.17, L.66, K.67, G.68, T.69, Y.71, W.76, N.230, A.231, S.233, N.235, T.236
13 PLIP interactions:13 interactions with chain C- Hydrophobic interactions: C:T.17, C:L.66
- Hydrogen bonds: C:N.13, C:T.17, C:T.17, C:K.67, C:K.67, C:T.69, C:T.69, C:S.233, C:N.235, C:N.235
- Salt bridges: C:K.67
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jin, M. et al., Human coronavirus HKU1 spike structures reveal the basis for sialoglycan specificity and carbohydrate-promoted conformational changes. Nat Commun (2025)
- Release Date
- 2025-05-14
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 14 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 31 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x 01: 5-acetamido-8-O-(5-acetamido-9-O-acetyl-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl)-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosonic acid
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jin, M. et al., Human coronavirus HKU1 spike structures reveal the basis for sialoglycan specificity and carbohydrate-promoted conformational changes. Nat Commun (2025)
- Release Date
- 2025-05-14
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C